Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Not Yet Recruiting

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

NCT06314828

Conditions: B-cell Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL

NCT06289959

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients

NCT06255704

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hematology Department of ShanXi Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not Yet Recruiting

Relmacabtagene Autoleucel in Hematologic Malignancies

NCT06142188

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Peking University International Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL

NCT06062641

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Ruijin Hospital Shanghai, Shanhai, China

View Trial Details

Not Yet Recruiting

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

NCT06049472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

NCT06049485

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

NCT05990985

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Bethune Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma

NCT05814848

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

NCT05596097

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Hospital of Lanzhou University Lanzhou, Gansu, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions